Summary of this article
IPO applicants who were allotted a minimum of one lot or 119 shares of Amanta Healthcare would have gained at least Rs 1,071 (Rs 135 - Rs 126 x 119) once the pharma company’s shares listed on the exchange.
Amanta Healthcare IPO was worth Rs 126 crore. The sterile injectable manufacturer's issue consisted of a fresh issuance of 10 million shares.
Soon after Amanta Healthcare shares were listed, 2.13 million shares of the pharma company traded hands on the NSE.
Amanta Healthcare Ltd shares made their debut on the NSE and BSE on September 9 with robust gains. Amanta Healthcare shares made their debut on the NSE at Rs 135 apiece, up 7 per cent compared to the issue price of Rs 126 apiece. The stock soon surged more than 10 per cent to trade at an early high of Rs 139 apiece. On the other hand, Amanta Healthcare Ltd shares made their debut on the BSE at Rs 134 apiece, up by 6.34 per cent.
Amanta Healthcare Listing Day Gain
IPO applicants who were allotted a minimum of one lot or 119 shares of Amanta Healthcare would have gained at least Rs 1,071 (Rs 135 - Rs 126 x 119) once the pharma company’s shares listed on the exchange. Soon after Amanta Healthcare shares were listed, 2.13 million shares of the pharma company traded hands on the NSE. The Gujarat based company’s total market capitalisation stood at Rs 533.17 crore.
Amanta Healthcare IPO: Offer Size
Amanta Healthcare IPO was worth Rs 126 crore. The sterile injectable manufacturer's issue consisted of a fresh issuance of 10 million shares. Amanta Healthcare IPO price band was fixed at Rs 120- Rs 126 per share.
Amanta Healthcare IPO: Subscription
The minimum lot size for application for retail investors was fixed at 1 lot or 119 shares, which aggregated to an investment of Rs 14,994. Amanta Healthcare IPO was oversubscribed 82.61 times in its subscription period which started on September 1 and ended on September 3. Investors across categories placed bids for over 578.2 million shares compared to the 7 million shares offered for subscription.
The sterile injectable manufacturer's non-institutional investors (NII) quota was booked 209.42 times. The Amanta Healthcare IPO was booked 54.98 times in the retail individual investor category. The medical device maker's issue was booked 35.86 times in the Qualified Institutional Buyers (QIB) category.
Amanta Healthcare: Promoters
Amanta Healthcare's promoters held 85.6 per cent stake in the company before the public issue. The promoters which include Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Ltd will reduce their stake to 63.56 per cent post-IPO.
Amanta Healthcare IPO: Objective
Amanta Healthcare will use the funds raised via the initial public offering to undertake civil construction work and acquire equipment, plant, and machinery to establish a new manufacturing line for its product, SteriPort, and a separate manufacturing line for SVP.
About Amanta Healthcare
Amanta Healthcare Ltd was incorporated in 1994. The company manufactures and markets several sterile liquid products and medical devices.
At the time of writing, shares of Amanta Healthcare were trading at Rs 133 apiece, down 1.48 per cent.
